Study Using the Medpulser Electroporation System With Bleomycin to Treat Head and Neck Cancer

NCT00198263 ↗

Phase 4 Completed 95 enrolled Inovio Pharmaceuticals

NaSingle-groupOpen-labelTreatment

Summary

The purpose of the trial is to study the safety and efficacy of the Medpulser Electroporation System with bleomycin in the treatment of head and neck cancer.

Timeline

Start: 2004-01
Primary completion: 2008-09
Completion: 2008-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Bleomycin	Unknown	0.25 ml	Other

Study Using the Medpulser Electroporation System With Bleomycin to Treat Head and Neck Cancer

Summary

Timeline

Drugs

Indications